Path 1049 from C00117 to C00002

Back to all pathways

Sources: D-Ribose 5-phosphate; (C00117)

Target:ATP; (C00002)

Z: 0.9
Composite map: C00117->C00002:[10->8,12->3,6->17,7->10,7->11,7->12,7->2,7->4,8->13]

Showing 1 best reactions for each rpair.

RPAIRReactionScoreEquation
RP07515R034250Glycine; + Lipoylprotein; <=> CO2; + S-Aminomethyldihydrolipoylprotein;
RP03774R041440Glycine; + ATP; + 5-Phosphoribosylamine; <=> 5'-Phosphoribosylglycinamide; + Orthophosphate; + ADP;
RP01319R011270H2O; + IMP; <=> 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide;
RP10096R069740Formate; + ATP; + 5'-Phosphoribosylglycinamide; <=> 5'-Phosphoribosyl-N-formylglycinamide; + Orthophosphate; + ADP;
RP04102R044630L-Glutamine; + ATP; + H2O; + 5'-Phosphoribosyl-N-formylglycinamide; <=> L-Glutamate; + 2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine; + Orthophosphate; + ADP;
RP00470R011280H2O; + IMP; <=> Hypoxanthine; + D-Ribose 5-phosphate;
RP04205R0697501-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide; + Formate; + ATP; <=> 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide; + Orthophosphate; + ADP;
RP00477R031400Oxygen; + D-Ribulose 1,5-bisphosphate <=> 3-Phospho-D-glycerate; + 2-Phosphoglycolate;
RP01384R012440Adenine; + H2O; <=> Hypoxanthine; + NH3;
RP04030R001820AMP; + H2O; <=> D-Ribose 5-phosphate; + Adenine;
RP03735R001340NADP+; + Formate; <=> CO2; + NADPH;
RP06373R009410NADP+; + 10-Formyltetrahydrofolate; + H2O; <=> CO2; + NADPH; + H+ + Tetrahydrofolate;
RP01262R010560D-Ribose 5-phosphate; <=> D-Ribulose 5-phosphate
RP05769R057040Glycine; + Acceptor; <=> CO2; + Reduced acceptor; + Hydrogen cyanide;
RP08184R0456001-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide; + 10-Formyltetrahydrofolate; <=> 1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide; + Tetrahydrofolate;
RP04204R0455901-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; <=> Fumarate; + 1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide;
RP03838R0420802-(Formamido)-N1-(5'-phosphoribosyl)acetamidine; + ATP; <=> Aminoimidazole ribotide; + Orthophosphate; + ADP;
RP00861R001900Diphosphate; + AMP; <=> 5-Phospho-alpha-D-ribose 1-diphosphate; + Adenine;
RP05304R057040Glycine; + Acceptor; <=> CO2; + Reduced acceptor; + Hydrogen cyanide;
RP04241R045910L-Aspartate; + ATP; + 1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate; <=> 1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole; + Orthophosphate; + ADP;
RP10839R072810D-Ribulose 5-phosphate <=> 3,4-Dihydroxy-2-butanone 4-phosphate + Formate;
RP03839R0420901-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate; <=> CO2; + Aminoimidazole ribotide;
RP07975R0420901-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate; <=> CO2; + Aminoimidazole ribotide;
RP00003R0412601-Alkyl-sn-glycerol; + ATP; <=> 1-Alkyl-sn-glycero-3-phosphate; + ADP;
RP01570R015230D-Ribulose 5-phosphate + ATP; <=> D-Ribulose 1,5-bisphosphate + ADP;
RP01128R008300Succinyl-CoA; + Glycine; <=> CoA; + CO2; + 5-Aminolevulinate;
RP00749R04325010-Formyltetrahydrofolate; + 5'-Phosphoribosylglycinamide; <=> 5'-Phosphoribosyl-N-formylglycinamide; + Tetrahydrofolate;
RP00056R001570AMP; + UTP; <=> UDP; + ADP;
RP07387R000240CO2; + D-Ribulose 1,5-bisphosphate + H2O; <=> 3-Phospho-D-glycerate;

Pathway diagram (see pathway with molecule structures instead)